glp 1 agonist therapy Frontiers Five Unexpected New Uses for

doi: 10.1016/j.jalz.2013.12.005

Enter semaglutide, one of a class of medicines the GLP-1-receptor agonists that imitate GLP-1, helping the body lower glucose (in the case of people with diabetes) and, researchers suspect, curb appetite (in the case of people living with obesity who may also have diabetes)

Additionally, P9 induces interleukin-6 (IL-6) secretion from the intestine, which subsequently stimulates GLP-1 secretion by intestinal L-cells and pancreatic -cells, and also affects Icam2 mRNA expression, which suggests the normal expression of Icam-2 and the effects of P9 in glucose homeostasis may require IL-6 [160] (Fig

J Clin Hypertens (Greenwich)

The portions of food Im eating are now smaller than my wifes

Many patients may find 8mg sufficient and not need to escalate to 12mg, especially if side effects are well-controlled at 8mg